Aromatase is the enzyme responsible for estrogen biosynthesis. Aromatase inhibitors (AIs) work by blocking the aromatase enzyme, thereby reducing estrogen production in postmenopausal women and inhibiting the growth of hormone receptor-positive breast cancer cells. Common AIs include anastrozole, letrozole, exemestane. Pharmacophore modeling is used to identify the chemical features responsible for a drug's binding and action. Molecular docking further elucidates the binding mode between aromatase inhibitors and the aromatase enzyme.